MENLO PARK, Calif.,
Dec. 6, 2016 /PRNewswire/
-- BioPharmX Corporation (NYSE MKT: BPMX), a specialty
pharmaceutical company focusing on dermatology, today announced
that it will release its financial results for the fiscal third
quarter ended Oct. 31, 2016 after the
close of trading on Tuesday, Dec. 13,
2016. The company's management team will host a
corresponding conference call beginning at 1:30 p.m. PT/4:30 p.m.
ET to discuss the financial results and recent business
developments.
Individuals interested in listening to the conference call may
do so by dialing (866) 652-5200 for domestic callers or (412)
317-6060 for international callers, and request to join the
BioPharmX Corporation call. To listen to a live webcast, please
visit the investor relations section of the BioPharmX website at:
www.BioPharmX.com.
A replay of the call will be available beginning Dec. 13 at 3:30 p.m.
PT/6:30 p.m. ET through
midnight ET on Jan. 12, 2017. To access the replay, dial (877)
344-7529 or (412) 317-0088 and reference Conference ID: 10097418.
The webcast will also be available on the BioPharmX website for 90
days following the completion of the call.
About BioPharmX® Corporation
BioPharmX Corporation
(NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical
company, that seeks to provide products through proprietary
platform technologies for prescription, over-the-counter (OTC), and
supplement applications in the health and wellness markets,
including dermatology and women's health. To learn more about
BioPharmX, visit www.BioPharmX.com.
Logo - http://photos.prnewswire.com/prnh/20150711/235327LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biopharmx-to-report-third-quarter-financial-results-300371949.html
SOURCE BioPharmX Corporation